Children with Chronic Myeloid Leukemia (CML)
SITES
International CML Foundation - Section on Pediatric CML
Junior CML Advocates
Children with cancer (UK)
Registration of Children With CML and Treatment With Imatinib (CML-paed II)
Seattle Cancer Care Alliance – Pediatrics (US)
Children's Hospital Boston
The International BFM Study Group
Aaron Bullingham’s site
Isabella Juliette Babione’s site
Medical Resources: Understanding Leukemia by Online Nursing Degrees
Saving Lives with Pediatric Stem Cell Transplant by Power Patient
FORUMS
Children with CML by CML Support (UK)
Cancercompass(Child1- before 20 years old)
Cancercompass(Child2 - after 20 years old)
-----------------------
Children with CML in Facebook (new group) (old group)
Children with CML by CML Support (UK)
Cancercompass(Child1- before 20 years old)
Cancercompass(Child2 - after 20 years old)
-----------------------
Children with CML in Facebook (new group) (old group)
VIDEOS
Katie's story: age 6
Dylan's story: age 9
Katie's story: age 22
Rob's story: age 22
The Bone Marrow - Factory of Life (for children)
Cancer survivors beat the odds, graduate high school
Believe in tomorrow
Katie's story: age 6
Dylan's story: age 9
Katie's story: age 22
Rob's story: age 22
The Bone Marrow - Factory of Life (for children)
Cancer survivors beat the odds, graduate high school
Believe in tomorrow
ARTICLES
Leukemia and Childhood Infection Hypothesis
Jul 30, 2019, News Medical
Risk of Hospitalization Remains High for Survivors of Childhood Leukemia
February 21, 2019, Oncology Nurse Advisor
Physiologically based pharmacokinetic modeling to supplement nilotinib pharmacokinetics and confirm
dose selection in pediatric patients
February 4, 2019, PubMed
Addressing Off-Target Effects of TKIs in Pediatric CML
December 10, 2018, OncLive
Practice Patterns of Physician Treatment for Pediatric Chronic Myeloid Leukemia (CML)
September 26, 2018, PubMed
Research Indicates Imatinib Is Effective in Pediatric Patients With Chronic Phase CML
July 19, 2018, Cancer Therapy Advisor
EC approves expanded indication for Sprycel
July 6, 2018, thepharmaletter
Dasatinib Approved in Europe for Pediatric Ph+ Chronic Phase CML
July 5, 2018, OncLive
Pediatric CML: Life-Long Considerations With TKI Therapy
May 22, 2018, Cancer Therapy Advisor
Tasigna cleared for use in children with rare leukemia
March 23, 2018, PharmaTimes
FDA Approves Nilotinib for Pediatric Chronic Myeloid Leukemia
March 22, 2018, Oncology Nursing News
Dasatinib: A Safe and Effective Option for Pediatric CML
March 5, 2018, Cancer Therapy Advisor
Pediatric CML: Imatinib Effective in the Front Line
February 22, 2018, Cancer Therapy Advisor
Advanced Phases at Diagnosis of Childhood Chronic Myeloid Leukemia : The Experience of the International
Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped Study)
December 2017, ASH 2017
Long-Term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib. the Italian Experience
December 2017, ASH 2017
Response to Front-Line Imatinib Treatment in Children and Adolescents with CML – Data from a Large Pediatric Cohort
December 2017, ASH 2017
Family, community rally around Bessemer girl battling leukemia
December 16 2016, New Castle News
Childhood CML Survival Worst for Children Under 5 Years Old
October 19, 2016, Cancer Therapy Advisor
Disparities in Childhood CML Outcomes Persist Among Some European Countries and the US
October 11, 2016, Cancer Therapy Advisor
Pediatric chronic myeloid leukemia is a unique disease that requires a different approach
October 23, 2015, Journal Blood
Cord Blood Transplant: In Children, One Will Do
October 29, 2014, Medscape
Waterloo girl receives trip of a lifetime
November 21, 2013, hngnews.com
Imatinib cessation in children and adolescents with chronic myeloid leukemia in chronic phase
September 17, 2013, Pediatric Blood & Cancer
Dasatinib Shows Promise for Pediatric CML, ALL Patients
September 13, 2013, Cancer Network
Ky. voices: Dr. John D'Orazio says funding for cures is slipping
December 2, 2012, Kentucky.com
Chronic myeloid leukemia in children and adolescents: Results of treatment with imatinib mesylate.
May 18, 2012, PubLmed
How I treat childhood CML
February 22, 2012, Journal Blood
Dreams still come true - Cancer survivor gives back to sick child through organization
February 1, 2012, The advocate
Analysis of outcomes in adolescents and young adults with CML treated with upfront tyrosine kinase inhibitortherapy
January 22, 2012,Heamatologica
Helping One of Their Own (Child with CML)
November 26, 2011, TheEveningSun
Imatinib has adverse effect on growth in children with chronic myeloid leukemia.
November 2, 2011, Pediatr Blood Cancer.
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
June 20, 2011, Journal of Clinical Oncology
Children’s Hospital Los Angeles Team Discovers Key to Fighting Drug-Resistant Leukemia
May 18, 2011, Enhanced Online News
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
May 5, 2011, Journal of Clinical Oncology
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation
March 25, 2011, PublMed
Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?
January 17, 2011, Unbound Medline
10 Years old Malay Girl with a Rare Chronic Myeloid Leukemia with Blast Crisis.
January 12, 2011, http://www.jacknaimsnotes.com
Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era;
January 2011, DocGuide.com
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
December 2010, Hematology
Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy.
December 22, 2010, Unbound Medline
Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia
December 5, 2010, ASH2010
Dasatinib In Children and Adolescents with Relapsed or Refractory Leukemia: Results of the CA180018 Phase 1 Dose-Escalation Study of the Innovative Therapies for Children with Cancer (ITCC) Consortium
December 5, 2010, ASH 2010
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
December 4, 2010,Hematology
Cost of Saving Michael’s Life: $600
December 4, 2010,Dr. Rick Hodes
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment
October 2010 (last modified), National Cancer Institute
Chronic myeloid leukemia in children less than two years (in French)
October 10, 2010, Université Paris Descartes
Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia
April 21, 2010, Haematologica
Impact of the type of the BCR-ABL fusion transcript on the molecular response in paediatric patients with chronic myeloid leukemia
February 2010, Haematologica
Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program.
February 2010, PubLMed.com
Imatinib Is Efficient but Has a Negative Impact On Growth in Children with Previously Untreated chronic Myelogenous Leukaemia (CML) in Early Chronic Phase (CP): Results of the French National Phase IV Trial
December 2009, ASH 2009
What Are the Dangers of Bone Marrow Transplant in Children With CML?
November 2009, Kay Wagers, eHow Contributor
Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I
November 2009, PubLMed.com
Growth deceleration in a girl treated with imatinib
January 20, 2009, The Japanese Society of Hematology
Molecular response of pediatric chronic myeloid leukemia (CML) with imatinib mesylate therapy
November 2008, Cancer Prevention research
Dasatinib in children and adolescents with relapsd or refractory leukemia preliminary results of the CA180018 PHASE I/II study from the ITCC CONSORTIUM
June 2008, 13th Congress of the European Hematology Association
Prognosis of pediatric patients transplanted for Ph+ chronic myeloid leukemia in the period from 1989 to 2006 in the Czech Republic
2008, Mendeley
Leucostase pulmonaire au cours d'une leucémie myéloïde chronique (in French)
2006, Santé tropicale.com
Clinical and Biological Features at Diagnosis in 40 Children With Chronic Myeloid Leukemia
July 2005 , Pediatrics
Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?
October 2004, PubLmed.gov
Early blastic transformation following complete cytogenetic response in a pediatric chronic myeloid leukemia patient treated with imatinib mesylate.
May 2004, PubLMed.gov
Stem cell transplantation extends lives of children with CML
Oct 2003, Transplant News
Build it and they will come (or will they?)
August 2003, Journal Blood
Stem cell transplantation for chronic myeloid leukemia in children
August 15, 2003, Journal Blood
Leukemia and Childhood Infection Hypothesis
Jul 30, 2019, News Medical
Risk of Hospitalization Remains High for Survivors of Childhood Leukemia
February 21, 2019, Oncology Nurse Advisor
Physiologically based pharmacokinetic modeling to supplement nilotinib pharmacokinetics and confirm
dose selection in pediatric patients
February 4, 2019, PubMed
Addressing Off-Target Effects of TKIs in Pediatric CML
December 10, 2018, OncLive
Practice Patterns of Physician Treatment for Pediatric Chronic Myeloid Leukemia (CML)
September 26, 2018, PubMed
Research Indicates Imatinib Is Effective in Pediatric Patients With Chronic Phase CML
July 19, 2018, Cancer Therapy Advisor
EC approves expanded indication for Sprycel
July 6, 2018, thepharmaletter
Dasatinib Approved in Europe for Pediatric Ph+ Chronic Phase CML
July 5, 2018, OncLive
Pediatric CML: Life-Long Considerations With TKI Therapy
May 22, 2018, Cancer Therapy Advisor
Tasigna cleared for use in children with rare leukemia
March 23, 2018, PharmaTimes
FDA Approves Nilotinib for Pediatric Chronic Myeloid Leukemia
March 22, 2018, Oncology Nursing News
Dasatinib: A Safe and Effective Option for Pediatric CML
March 5, 2018, Cancer Therapy Advisor
Pediatric CML: Imatinib Effective in the Front Line
February 22, 2018, Cancer Therapy Advisor
Advanced Phases at Diagnosis of Childhood Chronic Myeloid Leukemia : The Experience of the International
Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped Study)
December 2017, ASH 2017
Long-Term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib. the Italian Experience
December 2017, ASH 2017
Response to Front-Line Imatinib Treatment in Children and Adolescents with CML – Data from a Large Pediatric Cohort
December 2017, ASH 2017
Family, community rally around Bessemer girl battling leukemia
December 16 2016, New Castle News
Childhood CML Survival Worst for Children Under 5 Years Old
October 19, 2016, Cancer Therapy Advisor
Disparities in Childhood CML Outcomes Persist Among Some European Countries and the US
October 11, 2016, Cancer Therapy Advisor
Pediatric chronic myeloid leukemia is a unique disease that requires a different approach
October 23, 2015, Journal Blood
Cord Blood Transplant: In Children, One Will Do
October 29, 2014, Medscape
Waterloo girl receives trip of a lifetime
November 21, 2013, hngnews.com
Imatinib cessation in children and adolescents with chronic myeloid leukemia in chronic phase
September 17, 2013, Pediatric Blood & Cancer
Dasatinib Shows Promise for Pediatric CML, ALL Patients
September 13, 2013, Cancer Network
Ky. voices: Dr. John D'Orazio says funding for cures is slipping
December 2, 2012, Kentucky.com
Chronic myeloid leukemia in children and adolescents: Results of treatment with imatinib mesylate.
May 18, 2012, PubLmed
How I treat childhood CML
February 22, 2012, Journal Blood
Dreams still come true - Cancer survivor gives back to sick child through organization
February 1, 2012, The advocate
Analysis of outcomes in adolescents and young adults with CML treated with upfront tyrosine kinase inhibitortherapy
January 22, 2012,Heamatologica
Helping One of Their Own (Child with CML)
November 26, 2011, TheEveningSun
Imatinib has adverse effect on growth in children with chronic myeloid leukemia.
November 2, 2011, Pediatr Blood Cancer.
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
June 20, 2011, Journal of Clinical Oncology
Children’s Hospital Los Angeles Team Discovers Key to Fighting Drug-Resistant Leukemia
May 18, 2011, Enhanced Online News
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
May 5, 2011, Journal of Clinical Oncology
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation
March 25, 2011, PublMed
Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?
January 17, 2011, Unbound Medline
10 Years old Malay Girl with a Rare Chronic Myeloid Leukemia with Blast Crisis.
January 12, 2011, http://www.jacknaimsnotes.com
Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era;
January 2011, DocGuide.com
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
December 2010, Hematology
Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy.
December 22, 2010, Unbound Medline
Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia
December 5, 2010, ASH2010
Dasatinib In Children and Adolescents with Relapsed or Refractory Leukemia: Results of the CA180018 Phase 1 Dose-Escalation Study of the Innovative Therapies for Children with Cancer (ITCC) Consortium
December 5, 2010, ASH 2010
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
December 4, 2010,Hematology
Cost of Saving Michael’s Life: $600
December 4, 2010,Dr. Rick Hodes
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment
October 2010 (last modified), National Cancer Institute
Chronic myeloid leukemia in children less than two years (in French)
October 10, 2010, Université Paris Descartes
Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia
April 21, 2010, Haematologica
Impact of the type of the BCR-ABL fusion transcript on the molecular response in paediatric patients with chronic myeloid leukemia
February 2010, Haematologica
Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program.
February 2010, PubLMed.com
Imatinib Is Efficient but Has a Negative Impact On Growth in Children with Previously Untreated chronic Myelogenous Leukaemia (CML) in Early Chronic Phase (CP): Results of the French National Phase IV Trial
December 2009, ASH 2009
What Are the Dangers of Bone Marrow Transplant in Children With CML?
November 2009, Kay Wagers, eHow Contributor
Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I
November 2009, PubLMed.com
Growth deceleration in a girl treated with imatinib
January 20, 2009, The Japanese Society of Hematology
Molecular response of pediatric chronic myeloid leukemia (CML) with imatinib mesylate therapy
November 2008, Cancer Prevention research
Dasatinib in children and adolescents with relapsd or refractory leukemia preliminary results of the CA180018 PHASE I/II study from the ITCC CONSORTIUM
June 2008, 13th Congress of the European Hematology Association
Prognosis of pediatric patients transplanted for Ph+ chronic myeloid leukemia in the period from 1989 to 2006 in the Czech Republic
2008, Mendeley
Leucostase pulmonaire au cours d'une leucémie myéloïde chronique (in French)
2006, Santé tropicale.com
Clinical and Biological Features at Diagnosis in 40 Children With Chronic Myeloid Leukemia
July 2005 , Pediatrics
Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?
October 2004, PubLmed.gov
Early blastic transformation following complete cytogenetic response in a pediatric chronic myeloid leukemia patient treated with imatinib mesylate.
May 2004, PubLMed.gov
Stem cell transplantation extends lives of children with CML
Oct 2003, Transplant News
Build it and they will come (or will they?)
August 2003, Journal Blood
Stem cell transplantation for chronic myeloid leukemia in children
August 15, 2003, Journal Blood
